Skip to main content

Find Clinical Trials

Home
Conditions
Nasopharyngeal Neoplasms

Clinical trial condition

Nasopharyngeal Neoplasms

Explore clinical trials studying Nasopharyngeal Neoplasms. Study availability and eligibility vary by location and protocol.

336 public trials 129 recruiting studies

Refine in advanced search Browse all conditions

Nasopharyngeal Neoplasms trial results

Recruiting

Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma

NCT07362979

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Cancinoma (NPC), +12 more
Locations: Dongguan People's Hospital Dongguan, Guangdong, China

Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Shenzhen, Guangdong, China

Affiliated Hospital of Guangdong Medical University Zhanjiang, Guangdong, China

View Trial Details

Recruiting

Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC

NCT07459296

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +12 more
Locations: The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China

View Trial Details

Recruiting

Proton Therapy for Recurrent Nasopharyngeal Carcinoma

NCT07412314

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +12 more
Locations: Guangzhou Concord Cancer Center Guangzhou, Guangdong, China

Guangzhou concord cancer center Guanzhou, Guangzhou, China

View Trial Details

Recruiting

Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response

NCT06239727

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Fujian Cancer Hospital Fuzhou, Fujian, China

The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China

Dongguan People's Hospital Dongguan, Guangdong, China

The First People's Hospital of Foshan Foshan, Guangdong, China

View all 26 locations

View Trial Details

Recruiting

Sapylin Versus Dexamethasone Inhalation for CCRT-Induced Oral Mucositis in Nasopharyngeal Carcinoma

NCT07327216

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +12 more
Locations: Affiliated Hospital of Guangdong Medical University Zhanjiang, Guangdong, China

View Trial Details

Recruiting

TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

NCT06868433

Conditions: Carcinoma, Carcinoma, Squamous Cell, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +48 more
Locations: Emory University Hospital Midtown Atlanta, Georgia, United States

Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

View Trial Details

Recruiting

Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.

NCT06059261

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China

View Trial Details

Recruiting

Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial

NCT06636734

Conditions: Carcinoma, Carcinoma, Squamous Cell, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +43 more
Locations: Emory University Hospital Midtown Atlanta, Georgia, United States

Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

View Trial Details

Recruiting

Iparomlimab and Tuvonralimab Combined With Nimotuzumab in Recurrent or Metastatic NPC After First-line Treatment Failure: A Single-arm Phase IIa Clinical Trial

NCT07101744

Conditions: Carcinoma, First-line Treatment Failure Nasopharyngeal Carcinoma, Head and Neck Neoplasms, +13 more
Locations: Sun Yat-sen University Cancer Center Guangdong, China

View Trial Details

Recruiting

A Study of MRG003 in Combination With Pucotenlimab Versus Chemotherapy in the Treatment of Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

NCT06976190

Conditions: Carcinoma, Disease Attributes, Head and Neck Neoplasms, +16 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details